Rosetta Genomics Ltd. (NASDAQ:ROSG)’s share price traded down 4.7% during trading on Thursday . The stock traded as low as $1.35 and last traded at $1.42. 208,439 shares changed hands during mid-day trading, an increase of 130% from the average session volume of 90,700 shares. The stock had previously closed at $1.49.

The stock’s market capitalization is $2.54 million. The company’s 50-day moving average is $1.60 and its 200 day moving average is $2.37.

TRADEMARK VIOLATION NOTICE: This story was reported by Daily Political and is the sole property of of Daily Political. If you are reading this story on another site, it was illegally stolen and reposted in violation of US & international copyright and trademark legislation. The original version of this story can be read at

About Rosetta Genomics

Rosetta Genomics Ltd. is engaged in developing and commercializing new diagnostic tests based on various genomics markers, including deoxyribonucleic acid (DNA), micro ribonucleic acid (microRNA) and protein biomarkers and using various technologies, including, Quantitative polymerase chain reaction (qPCR), microarrays, Next Generation Sequencing (NGS) and Fluorescence In Situ Hybridization (FISH).

Receive News & Ratings for Rosetta Genomics Ltd. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Rosetta Genomics Ltd. and related companies with's FREE daily email newsletter.